Harvard Update in Clinical Cardiology 2024

1. The New Role of the Cardiologist in Obesity and Diabetes Management – James L. Januzzi, MD

2. Q&A Session – James L. Januzzi, MD

3. Dyslipidemia: Latest Concepts and Treatments – Pradeep Natarajan, MD

4. Q&A Session – Pradeep Natarajan, MD

5. CV Prevention: Instructive Cases and Panel Discussion – James L. Januzzi, MD and Pradeep Natarajan, MD

1. Aortic Stenosis: Timing of Intervention and Choosing between Surgery and Percutaneous Therapy – Nilay Patel, MD

2. Q&A Session – Nilay Patel, MD

3. Mitral Regurgitation: Timing of Intervention and Choosing between Surgery and Percutaneous Therapy – Jonathan Passeri, MD

4. Q&A Session – Jonathan Passeri, MD

5. Tricuspid Regurgitation and Transcatheter Therapy – Evin Yucel, MD

6. Valvular Heart Disease: Instructive Cases and Panel Discussion – Nilay Patel, MD; Jonathan Passeri, MD; and Evin Yucel, MD

1. Advances in Medical Treatment of Systolic Heart Failure – Daniel Zlotoff, MD, PhD

2. Q&A Session – Daniel Zlotoff, MD, PhD

3. Advanced Heart Failure: Acute and Chronic Therapy – Erin Coglianese, MD

4. Q&A Session – Erin Coglianese, MD

5. Heart Failure with Preserved Ejection Fraction (HFpEF) – Gregory D. Lewis, MD

6. Q&A Session – Gregory D. Lewis, MD

7. Critical Care Cardiology in 2024 – David Dudzinski, MD, JD

8. Heart Failure: Instructive Cases and Panel Discussion – Daniel Zlotoff, MD, PhD; Erin Coglianese, MD; Gregory D. Lewis, MD; and David Dudzinski, MD, JD

1. Atrial Fibrillation: Recent Advances in Pharmacologic and Nonpharmacologic Therapy – Moussa Mansour, MD

2. Q&A Session – Moussa Mansour, MD

3. The Newest Approaches to Stroke Prevention in Atrial Fibrillation – Kevin Heist, MD, PhD

4. Q&A Session – Kevin Heist, MD, PhD

5. Atrial Fibrillation: Instructive Cases and Panel Discussion – Moussa Mansour, MD and Kevin Heist, MD, PhD

6. Ventricular Tachycardia: Advances in Pharmacologic and Nonpharmacologic Therapy – William Hucker, MD, PhD

7. Q&A Session – William Hucker, MD, PhD

8. Monitors, Wearables, AF Detection – Shaan Khurshid, MD, MPH

9. Q&A Session – Shaan Khurshid, MD, MPH

10. Adolph M. Hutter, Jr., MD, Keynote Lecture: Sensors, Artificial Intelligence (AI) and the Future of Cardiovascular Care – Jagmeet Singh, MD, PhD

11. Q&A Session – Jagmeet Singh, MD, PhD

1. State-of-the-Art Approaches to Peripheral Arterial Disease – Douglas E. Drachman, MD

2. Q&A Session – Douglas E. Drachman, MD

3. Pulmonary Embolism – Gaurav Parmar, MD

4. Q&A Session – Gaurav Parmar, MD

5. Treating Vascular Disease in 2024: Instructive Cases and Panel Discussion – Douglas E. Drachman, MD; Gaurav Parmar, MD; and Joseph Garasic, MD

1. Thoracic Aortic Disease: Updates from New Practice Guidelines – Eric M. Isselbacher, MD

2. Q&A Session – Eric M. Isselbacher, MD

3. Management of Acute and Recurrent Pericarditis – Jonathan Salik, MD, MS

4. Q&A Session – Jonathan Salik, MD, MS

1. Acute Coronary Syndromes – NSTEMI and STEMI: New Data and Clinical Implications – Marc Sabatine, MD, MPH

2. Q&A Session – Marc Sabatine, MD, MPH

3. Updates for Dual Antiplatelet Therapy in Cardiovascular Disease – Michelle L. O’Donoghue, MD

4. Q&A Session – Michelle L. O’Donoghue, MD

5. INOCA: Ischemia with Non-Obstructive Coronary Arteries – Emily S. Lau, MD, MPH

6. Q&A Session – Emily S. Lau, MD, MPH

7. Coronary Disease: Medicate/Dilate/Operate – Rahul Sakhuja, MD, MPP

8. Q&A Session – Rahul Sakhuja, MD, MPP

9. Interventional Cardiology: Instructive Cases and Panel Discussion – Rahul Sakhuja, MD, MPP; Farouc Jaffer, MD, PhD; Akl Fahed, MD; and Darshan Doshi, MD

1. State-of-the-Art Approaches to Cardio-Oncology – Tomas Neilan, MD, MPH, MRCPI

2. Q&A Session – Tomas Neilan, MD, MPH, MRCPI

3. Cardiomyopathies with Increased Wall Thickness (HCM and Amyloid) – Albree Tower-Rader, MD and Hanna Gaggin, MD, MPH

4. Q&A Session – Albree Tower-Rader, MD and Hanna Gaggin, MD, MPH

5. Sports Cardiology – J. Sawalla Guseh, MD

6. Q&A Session – J. Sawalla Guseh, MD

7. Update in Cardiovascular Disease and Pregnancy – Nandita Scott, MD

8. Q&A Session – Nandita Scott, MD

9. Closing Remarks – Rory B. Weiner, MD